H
Harmony Biosciences Holdings, Inc.
HRMY · NASDAQ · Healthcare · 2.2B
Closing price
$40.28
+1.72% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
14.6×
Price / net assetsP/B
2.7×
Enterprise value / EBITDAEV/EBITDA
7.1×
Free cash flow yieldFCF yield
15.0%
Return on equityROE
18.2%
Operating margin
24.0%
Net debt / EBITDAbalance-sheet strength
-2.0×
Interest coverage
14.2×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.